Drugs and Devices

FDA approves drug for ALS

On May 5, the U.S. Food and Drug Administration (FDA) approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares